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Background: Pathologic intimal thickening (PIT) plaque phenotype is an early stage
of coronary atherosclerosis. It has been identiﬁed as a protective plaque phenotype in
the PROSPECT trial. Unlike other trials that have used a frame-based deﬁnition for a
plaque phenotype, we analyzed the vessel in 5 mm 3D segments of contiguous ECG-
gated frames.
Methods: 32 patients with stable coronary artery disease and IVUS/VH data suitable
for geometrically-correct 3 D reconstruction and quantitative analysis were retro-
spectively identiﬁed from a database containing 50 patients with baseline and
12 months follow-up IVUS of a non-culprit vessel. Volumetric and plaque-type
indices were obtained from 5 mm long, adjacent, non-overlapping segments covering
the entire length of the IVUS pullbacks. We analyzed total number of 280 segments of
5 mm length. The inclusion cut-off point for plaque was plaque burden >40%. Pla-
ques were divided into four categories according to the AHA classiﬁcation: pathologic
intimal thickening (PIT), ﬁbrous plaque (FP), ﬁbro-calciﬁed plaque (FcP), thick-cap
ﬁbro-atheroma (ThCFA) and thin-cap ﬁbro-atheroma (TCFA). Risk score (RS) for all
plaques was determined as follows: no lesion (NL) 0; PIT 1; FP 2; FcP 3; ThCFA 4;
TCFA 5 points. Corresponding 5 mm vessel segments were compared between BL
and follow-up.
Results: The mean change in RS for plaque phenotypes was: 0.48 for NL; 2.55 for
PIT; 1.88 for FP; 1.2 for FcP; -0.06 for ThCFA; and, -0.57 for TCFA. The differences
between changes of RS in PIT plaque phenotype versus other plaque phenotypes were
statistically highly signiﬁcant, except for comparison between PIT and FcP, where the
p value was 0.08 (note that only 5 FcP segments were identiﬁed at baseline overall).
New TCFA’s and ﬁbro-atheromas originated from PIT at rates of 53 % and 58.7%,
respectively.
Conclusions: PIT is the plaque phenotype that exhibited the most signiﬁcant changes
of plaque morphology between baseline and follow-up and is a primary source of new
ﬁbro-atheromas.
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Background: Baseline to 1-year plaque progression on intravascular ultrasound
(IVUS) predicts development of transplant coronary artery disease (TCAD). It is not
known whether plaque on baseline IVUS immediately after cardiac transplantation
predicts TCAD.
Methods: Between January 2010 and October 2011, routine left anterior descending
(LAD) IVUS were performed on 59 transplant recipients. Maximal stenosis by area
in percentage was measured in a blinded manner with quantiﬁcation software. A
ROC curve was performed to determine an optimal cutoff for freedom from
angiographic signiﬁcant TCAD 30%, and outcomes compared between the two
groups.
Results: Mean age at cardiac transplantation was 53.6  13.2 years. Baseline
IVUS were done 45.1  14.7 days after transplantation with an average segment
length of 35.7  5.0 mm. Average maximal stenosis by area was 18.5  13.6%.
Angiographic signiﬁcant TCAD 30% was found in 7 of 59 (11.9%) patients;
only 1 of 7 cases of TCAD was present at one-year angiography. Mean angio-
graphic follow up was 30.7  8.6 months. The area under the curve on ROC
analysis was 81.6%, and an optimal maximal stenosis cutoff of 20% was chosen
corresponding with a sensitivity of 85.7% and speciﬁcity of 76.9% to predict
downstream TCAD. Maximal stenosis on baseline IVUS >20% predicted poor
freedom from TCAD p < 0.001 (Log rank test). Interestingly, the majority of
TCAD (57.1%) was predominantly non-LAD or diffuse disease despite IVUS only
of the LAD.
Conclusions: Maximal stenosis seen on baseline IVUS 20% predicts downstream
CAV even in non-LAD distributions.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/ImTCT-355
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Background: Intravascular ultrasound (IVUS) more accurately determines vessel size
and lesion severity and estimate a detailed plaque composition than conventional
coronary angiography. But there is controversy whether use of IVUS for treating
coronary artery disease (CAD) with percutaneous coronary intervention (PCI) im-
proves better clinical outcome.
Methods: Among 4,980 consecutive patients underwent PCI for CAD were
analyzed from the TRI retrospective registry, data from 4,466 patients after
excluding the patients with inhospital mortality and inappropriate data for PCI and
clinical outcome were analyzed. The patients were divided into two groups whether
IVUS was used (IVUS-guided PCI group; n ¼ 1,191) or not (angio-guided PCI
group; n ¼ 3,275) during PCI. Major adverse cardiac event (MACE) was a com-
posite of any death, myocardial infarction and any revascularization at 1-year of
clinical follow-up.
Results: Age was similar between two groups (64.3  11.5 years in angio-guided
PCI group vs. 64.7  10.5 years in IVUS-guided PCI group; p ¼ 0.297) but male
were dominant (67.3% vs. 63.1%; p ¼ 0.011). History of hypertension (55.4% vs.
59.7%; p ¼ 0.012), diabetes (30.4% vs. 33.8%; p ¼0.034), smoking (39.8% vs.
51.6%; p < 0.001), and previous myocardial infarction (MI) (4.5% vs. 7.8%;
p < 0.001) were frequent in IVUS-guided PCI group. The rate of stable angina
(15.4% vs. 20.8%; p < 0.001) was higher but the rate of acute MI (39.5% vs. 31.2%;
p < 0.001) was lower in IVUS-guided PCI group. Discharge medication was similar
except use of clopidogrel (98.1% vs. 99.2%; p ¼ 0.011), beta blocker (63.0% vs.
69.7%; p < 0.001), and statin (84.9% vs. 81.2%; p ¼ 0.004). In IVUS-guided PCI
group, more number of stent (1.6  0.9 vs. 1.9  1.2; p < 0.001) with larger
diameter (3.1  0.4 mm vs. 3.2  0.4 mm; p < 0.01) and longer length (38.2  24.0
mm vs. 45.2  32.1 mm; p < 0.001) were used. The incidence of MACE (6.1% vs.
7.0%; p ¼ 0.298) and stent thrombosis (0.7% vs. 0.9%, p ¼ 0.565) were similar
between two groups. On multivariate analysis, the use of IVUS was not a factor for
MACE.
Conclusions: In our retrospective registry, IVUS-guided PCI in patients with CAD
did not improve the clinical outcome and stent thrombosis.aging Intravascular - IVUS B103
